This medication is a pain reliever belonging to the group of medications known as nonsteroidal anti-inflammatory drugs (NSAIDs).
Enandol is used in adults for the short-term symptomatic treatment of mild to moderate acute pain, such as muscle pain or joint pain (e.g., back pain, sprains, and acute trauma), menstrual pain, and dental pain.
Do not take Enandol:
-If you are allergic to dexketoprofen or any of the other components of this medication (listed in section 6);
-If you are allergic to acetylsalicylic acid or another nonsteroidal anti-inflammatory drug;
-If you have asthma or have had asthma attacks, acute allergic rhinitis (a short period of nasal mucosa inflammation), nasal polyps (fleshy formations in the nasal cavity due to allergy), urticaria (skin rash), angioedema (swelling of the face, eyes, lips, or tongue, or difficulty breathing), or chest wheezing after taking acetylsalicylic acid or other nonsteroidal anti-inflammatory drugs;
-If you have had photoallergic or phototoxic reactions (a special form of skin redness or burns exposed to sunlight) during the use of ketoprofen (a nonsteroidal anti-inflammatory drug) or fibrates (medications used to reduce blood lipid levels);
-If you have chronic inflammatory bowel disease (Crohn's disease or ulcerative colitis);
-If you have severe heart failure, moderate to severe kidney failure, or severe liver failure;
-If you have bleeding disorders or blood clotting disorders;
-If you are severely dehydrated (have lost a lot of body fluid) due to vomiting, diarrhea, or inadequate fluid intake;
-If you are in the third trimester of pregnancy or breastfeeding.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Enandol:
-If you have kidney, liver, or heart diseases (hypertension and/or heart failure), or have had these conditions in the past;
-If you are taking diuretics or have inadequate hydration and reduced blood volume due to excessive fluid loss (e.g., excessive urination, diarrhea, or vomiting);
-If you have heart problems, a history of strokes, or think you may be at risk of these conditions (e.g., high blood pressure, diabetes, high cholesterol, or smoking) consult this treatment with your doctor or pharmacist. Enandol may be associated with a small increase in the risk of heart attacks ("myocardial infarction") or strokes ("cerebrovascular accident"). Any risk is more likely to occur when using high doses and prolonged treatments. Do not exceed the recommended dose or treatment duration;
-If you are an elderly patient, you may be more likely to experience adverse effects (see section 4). If these occur, consult your doctor immediately;
-If you are a woman with fertility problems (see section 2, "Pregnancy, lactation, and fertility");
-If you have a disorder in blood production and cell formation;
-If you have systemic lupus erythematosus or mixed connective tissue disease (autoimmune diseases affecting connective tissue);
-If you have had or have chronic inflammatory bowel disease (ulcerative colitis, Crohn's disease);
-If you have had or have gastrointestinal or intestinal disorders;
-If you have an infection; see the "Infections" heading below;
-If you are taking other medications that increase the risk of stomach ulcers or bleeding, for example, oral corticosteroids, some antidepressants (SSRI type), blood clotting agents such as acetylsalicylic acid (aspirin) or warfarin. In these cases, consult your doctor before taking this medication: your doctor may prescribe an additional medication to protect your stomach (e.g., misoprostol or other medications that block stomach acid production);
-If you have asthma, combined with allergic rhinitis or chronic sinusitis, and/or nasal polyps, as you have a higher risk of being allergic to acetylsalicylic acid and/or NSAIDs than the general population. Administration of this medication may cause asthma attacks or bronchospasm, particularly in patients allergic to acetylsalicylic acid or NSAIDs.
Infections
Enandol may mask the signs of an infection, such as fever and pain. Therefore, it is possible that this medication may delay the appropriate treatment of the infection, increasing the risk of complications. This has been observed in pneumonia caused by bacteria and bacterial skin infections related to chickenpox. If you take this medication while having an infection and the infection symptoms persist or worsen, consult a doctor without delay.
Avoid using this medication if you have chickenpox.
Children and adolescents
This medication has not been studied in children or adolescents. Therefore, safety and efficacy have not been established and should not be used in children or adolescents.
Use of Enandol with other medications
Inform your doctor or pharmacist if you are taking or have taken recently or may need to use any other medication, including those purchased without a prescription. There are some medications that should not be taken together and other medications that may require a dose change if taken together.
Always inform your doctor, dentist, or pharmacist if, in addition to this medication, you are taking any of the following medications:
Non-recommended associations:
-Acetylsalicylic acid, corticosteroids, and other anti-inflammatory drugs;
-Warfarin, heparin, and other medications used to prevent blood clotting;
-Lithium, used to treat mood disorders;
-Metotrexate (cancer and immunosuppressant medication), used at high doses of 15mg/week;
-Hidantoins and phenytoin, used for epilepsy;
-Sulfamethoxazole, used for bacterial infections.
Associations requiring caution:
-Inhibitors of the ECA, diuretics, and angiotensin II antagonists, used for high blood pressure and heart conditions;
-Pentoxifylline and oxpentifylline, used to treat chronic venous ulcers;
-Zidovudine, used to treat viral infections;
-Aminoglycoside antibiotics, used for bacterial infections;
-Sulfonilureas (e.g., chlorpropamide and glibenclamide), used for diabetes;
-Metotrexate, used at low doses, less than 15mg/week.
Associations to consider:
-Quinolones (e.g., ciprofloxacin, levofloxacin), used for bacterial infections;
-Ciclosporin or tacrolimus, used to treat autoimmune diseases and organ transplants;
-Streptokinase and other thrombolytic and fibrinolytic medications; that is, medications used to break down blood clots;
-Probenecid, used for gout;
-Digoxin, used in the treatment of chronic heart failure;
-Mifepristone, used as an abortifacient (to interrupt pregnancy);
-SSRI antidepressants;
-Antiplatelet agents used to reduce platelet aggregation and blood clot formation;
If you have any doubts about taking other medications with Enandol, consult your doctor or pharmacist.
Taking Enandol with food, drinks, and alcohol
Generally, it is recommended to take the medication with meals to reduce the possibility of causing stomach problems (see also section 3, "Administration form").
The use of NSAIDs in combination with alcohol may worsen the adverse reactions caused by the active ingredient.
Pregnancy, lactation, and fertility
Do not take this medication during the last three months of pregnancy or while breastfeeding.It may cause kidney and heart problems in your fetus. It may affect your predisposition and that of your baby to bleeding and delay or prolong delivery more than expected.
This medication may harm fertility, so it is not recommended to use this medication while trying to conceive or while studying a fertility problem.
Driving and operating machinery
This medication may slightly affect your ability to drive and operate machinery, as it may cause drowsiness, dizziness, and blurred vision as adverse effects of treatment. If you notice these effects, do not use machinery or drive until these symptoms disappear. Consult your doctor.
Enandol contains sodium
This medication contains less than 23 mg of sodium (1mmol) per tablet; that is, it is essentially "sodium-free".
Follow exactly the medication administration instructions contained in this leaflet or those indicated by your doctor or pharmacist. In case of doubt, ask your doctor or pharmacist.
The necessary dose of the medication may vary depending on the type, intensity, and duration of the pain.
The most effective dose should be used for the shortest time necessary to alleviate symptoms. If you have an infection, consult a doctor immediately if symptoms (such as fever and pain) persist or worsen (see section 2).
The tablets can be divided into equal doses.
Adults aged 18 years and older
The recommended dose is generally 1 tablet (25 mg of dexketoprofen) every 8 hours, without exceeding 3 tablets a day (75 mg).
Patients of advanced age or with renal or hepatic insufficiency
If you are an elderly patient, or you suffer from mild renal problems or mild to moderate liver problems, it is recommended to start treatment with a maximum of 2 tablets a day (50 mg of dexketoprofen).
In elderly patients, this initial dose can be increased subsequently in accordance with the general recommended dose (75 mg of dexketoprofen) if dexketoprofen has been well tolerated.
You should not use dexketoprofen if you suffer from moderate or severe renal problems, or severe liver problems. Consult your doctor or pharmacist if you are unsure.
Use in children and adolescents
This medication should not be used in children and adolescents (under 18 years).
Administration form
Take the tablets with an adequate amount of water.
The medication can be taken with or without food. Taking the medication with food helps to reduce the risk of gastrointestinal disorders, however, if your pain is more intense and you need faster relief, take the tablet on an empty stomach (at least 30 minutes before any meal or ingestion of food) because it will be absorbed more easily (see section 2 "Taking Enandol with food, drinks, and alcohol").
Treatment duration
Treatment should not exceed 4 days. If the pain persists after this period of time, worsens, or other symptoms appear, you should interrupt treatment and consult your doctor or pharmacist.
If you take more Enandol than you should
Consult your doctor, pharmacist, or call the Toxicological Information Service, phone 91.562.04.20, indicating the medication and the amount taken. It is recommended to bring the packaging and the leaflet of the medication to the healthcare professional.
If you forgot to take Enandol
Do not take a double dose to compensate for the missed doses. Take the next dose when due (in accordance with section 3 “How to take Enandol”).
If you have doubts about the use of this medication, consult your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
The possible side effects are listed below in order of frequency.
Frequent side effects(may affect up to 1 in 10 people):
Nausea and/or vomiting, mainly upper abdominal pain, diarrhea, digestive disorders (dyspepsia).
Less frequent side effects(may affect up to 1 in 100 people):
Rotatory sensation (dizziness), dizziness, drowsiness, sleep disorders, nervousness, headache, palpitations, hot flashes, stomach wall inflammation (gastritis), constipation, dry mouth, flatulence, skin rash, fatigue, pain, feverish sensation, and chills, general discomfort.
Rare side effects(may affect up to 1 in 1,000 people):
Peptic ulcer, perforation of peptic ulcer or bleeding (which may manifest with vomiting blood or black stools), fainting, high blood pressure, slow breathing, fluid retention and peripheral swelling (e.g., swelling of ankles), laryngeal edema, loss of appetite (anorexia), abnormal sensation, pruritic rash, acne, increased sweating, lower back pain, frequent urination, menstrual disorders, prostate disorders, abnormal liver function tests (blood analysis), liver cell damage (hepatitis), acute renal insufficiency.
Very rare(may affect up to 1 in 10,000 people):
Anaphylactic reaction (hypersensitivity reaction that can also lead to collapse), skin ulcers, mouth, eye, and genital area (Stevens-Johnson syndrome and Lyell syndrome), facial swelling or lip and throat swelling (angioedema), respiratory difficulty due to airway constriction (bronchospasm), shortness of breath, tachycardia, low blood pressure, pancreatitis inflammation, blurred vision, tinnitus, sensitive skin, light sensitivity, itching, kidney problems. Decreased white blood cell count (neutropenia), decreased platelet count (thrombocytopenia).
Inform your doctor immediately if you notice any gastrointestinal side effects at the start of treatment (e.g., stomach pain or burning, or bleeding), if you have previously experienced any of these side effects due to prolonged treatment with anti-inflammatory agents, and especially if you are elderly.
Stop taking this medicine immediately if you notice the appearance of a skin rash or any lesions inside the mouth or on the genitals, or any other sign of allergy.
During treatment with nonsteroidal anti-inflammatory drugs, cases of fluid retention and swelling (especially in ankles and legs), increased blood pressure, and heart failure have been reported.
Medicines like Enandol may be associated with a small increased risk of suffering a heart attack (“myocardial infarction”) or a stroke (“cerebral infarction”).
In patients with autoimmune disorders affecting connective tissue (systemic lupus erythematosus or mixed connective tissue disease), anti-inflammatory drugs may rarely cause fever, headache, and neck stiffness.
The most commonly observed side effects are of a gastrointestinal nature. They may cause peptic ulcers, perforation, or gastrointestinal bleeding, sometimes fatal, especially in elderly patients.
After administration, nausea, vomiting, diarrhea, flatulence, constipation, dyspepsia, abdominal pain, melena, hematemesis, ulcerative stomatitis, worsening of colitis, and Crohn's disease have been reported. Less frequently, gastric wall inflammation (gastritis) has been observed.
Like other NSAIDs, hematological reactions (purpura, aplastic and hemolytic anemia, and more rarely agranulocytosis and medullary hypoplasia) may appear.
Reporting of side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this prospectus.You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:www.notificaRAM.es.
By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging and on the blister pack after CAD. The expiration date is the last day of the month indicated.
Do not store above 30 °C. Store the blister pack in the original packaging to protect it from light.
Medications should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of unused packaging and medications. By doing so, you will help protect the environment.
Composition of Enandol
Tablet core:cornstarch, microcrystalline cellulose, sodium carboxymethyl starch (Type A) (potato starch), glyceryl distearate.
Tablet coating: dry lacquer composed of: hypromellose, titanium dioxide, and macrogol 6000, and propylene glycol (E-1520).
Appearance of Enandol and contents of the packaging
Coated, scored, white, and round tablets.
Available in packaging containing 10 and 16 coated tablets.
The tablets are presented in blisters (PVC-aluminium blisters).
Marketing Authorization Holder
MENARINI CONSUMER HEALTHCARE, S.A.U.
Guifré, 724 - 08918 Badalona (Barcelona) Spain
Responsible Manufacturer
LABORATORIOS MENARINI, S.A.
Alfons XII, 587 – 08918 Badalona (Barcelona) Spain
or
A. MENARINI MANUFACTURING LOGISTICS AND SERVICES, s.r.l.
Via Campo di Pile s/n – L’AQUILA – Italy
Last review date of this leaflet:April 2023
Other sources of information
The detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/.
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.